- Title: Subtitle
- Tolerability of pegunigalsidase alfa across the clinical program: Integrated analysis of infusion-related reactions by prior enzyme replacement therapy
- Creators
- Ankit Mehta - Baylor University Medical CenterEric Wallace - University of AlabamaAleš Linhart - Charles UniversityDerralynn Hughes - University College London Hospitals NHS Foundation TrustNicola Longo - University of UtahCamilla Tøndel - University of BergenBojan Vujkovac - Šolski center Slovenj GradecRossana Rocco - Chiesi Farmaceutici S.p.A., Parma, ItalyIrene Koulinska - Chiesi USA, Inc., Boston, MA, USARaul Chertkoff - Protalix BioTherapeuticsSari Alon - Protalix BioTherapeuticsAnat Sakov - DataSights, Haifa, IsraelJohn Bernat - University of Iowa
- Resource Type
- Abstract
- Publication Details
- Molecular genetics and metabolism, Vol.141(2), 107962
- Publisher
- Elsevier Inc
- DOI
- 10.1016/j.ymgme.2023.107962
- ISSN
- 1096-7192
- eISSN
- 1096-7206
- Language
- English
- Date published
- 02/2024
- Academic Unit
- Stead Family Department of Pediatrics; Medical Genetics and Genomics
- Record Identifier
- 9984557858402771
Abstract
Tolerability of pegunigalsidase alfa across the clinical program: Integrated analysis of infusion-related reactions by prior enzyme replacement therapy
Molecular genetics and metabolism, Vol.141(2), 107962
02/2024
DOI: 10.1016/j.ymgme.2023.107962
Details
Metrics
10 Record Views